UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Drugs (New York, N.Y.), ISSN 0012-6667, 3/2012, Volume 72, Issue 5, pp. 585 - 617
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Antifibrinolytics | Adis-Drug-Evaluations | Haemorrhage | Surgical-blood-loss | Menorrhagia | Tranexamic-acid | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Miscellaneous | Medical sciences | Pharmacology. Drug treatments | Antifibrinolytic Agents - therapeutic use | Fibrinolysis - drug effects | Cost-Benefit Analysis | Humans | Antifibrinolytic Agents - adverse effects | Hemorrhage - prevention & control | Tranexamic Acid - therapeutic use | Tranexamic Acid - adverse effects | Randomized Controlled Trials as Topic | Usage | Care and treatment | Tranexamic acid | Research | Blood diseases | Risk factors | Antifibrinolytic agents | Index Medicus
Journal Article
Thrombosis research, ISSN 0049-3848, 2014, Volume 135, Issue 2, pp. 231 - 242
Hematology, Oncology and Palliative Medicine | Tranexamic acid | Antifibrinolytics | Fibrinolysis | Bleeding | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Female | Hemorrhage - drug therapy | Antifibrinolytic Agents - adverse effects | Humans | Tranexamic Acid - adverse effects | Thromboembolism | Cardiac patients | Analysis | Index Medicus | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Anesthesiology (Philadelphia), ISSN 0003-3022, 03/2014, Volume 120, Issue 3, pp. 639 - 649
Neurology | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy | Biological and medical sciences | Anesthesia | Medical sciences | Nervous system (semeiology, syndromes) | Amygdala - drug effects | Mice, Inbred C57BL | Tranexamic Acid - pharmacology | Male | Patch-Clamp Techniques - methods | Seizures - chemically induced | Animals | Photolysis | Receptors, GABA-A - drug effects | Antifibrinolytic Agents - pharmacology | Synaptic Transmission - drug effects | Mice | Electric Stimulation - methods | Disease Models, Animal | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9734, pp. 23 - 32
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Antifibrinolytic Agents - therapeutic use | Hemorrhage - therapy | Humans | Wounds and Injuries - complications | Hemorrhage - mortality | Male | Tranexamic Acid - therapeutic use | Hemorrhage - drug therapy | Blood Transfusion | Thrombosis - etiology | Hemorrhage - etiology | Adult | Female | Thrombosis - prevention & control | Prevention | Complications and side effects | Tranexamic acid | Dosage and administration | Research | Blood transfusion | Health aspects | Hemorrhage | Risk factors | Colleges & universities | Clinical trials | Blood pressure | Charitable foundations | Trauma | Injuries | Binding sites | Teaching hospitals | Index Medicus | Abridged Index Medicus
Journal Article
Annals of neurology, ISSN 0364-5134, 01/2016, Volume 79, Issue 1, pp. 18 - 26
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Antifibrinolytic Agents - pharmacokinetics | Animals | Humans | Seizures - drug therapy | Tranexamic Acid - pharmacology | Tranexamic Acid - pharmacokinetics | Antifibrinolytic Agents - adverse effects | Tranexamic Acid - adverse effects | Seizures - chemically induced | Acids | Index Medicus | Review
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2017, Volume 376, Issue 2, pp. 136 - 148
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antifibrinolytic Agents - therapeutic use | Coronary Artery Disease - surgery | Thrombosis - chemically induced | Humans | Middle Aged | Male | Antifibrinolytic Agents - adverse effects | Hemorrhage - prevention & control | Blood Transfusion - statistics & numerical data | Seizures - chemically induced | Heart Valves - surgery | Reoperation - statistics & numerical data | Aged, 80 and over | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Postoperative Complications - chemically induced | Double-Blind Method | Intraoperative Complications - prevention & control | Coronary Artery Disease - mortality | Tranexamic Acid - therapeutic use | Tranexamic Acid - adverse effects | Coronary Artery Bypass | Aged | Hemorrhage - chemically induced | Usage | Care and treatment | Tranexamic acid | Diagnosis | Hemorrhage | Patients | Health aspects | Risk factors | Coronary arteries | Heart | Surgical outcomes | Myocardial infarction | Cerebral infarction | Aspirin | Heart surgery | Coronary artery | Clinical trials | Bleeding | Embolism | Tamponade | Acids | Intestine | Coronary vessels | Surgery | Renal failure | Seizures | Index Medicus | Abridged Index Medicus
Journal Article